Osteonecrosis clinical trials
The registry lists 286 studies for Osteonecrosis across more than 10 countries. 45 are recruiting or about to start. 102 of them are mainly about Osteonecrosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02. Counting its 2 narrower conditions too, such as Femur Head Necrosis: 353 studies, 61 open.
Get an email when these change. Save the Osteonecrosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Zimmer Biomet (46) · DePuy International (17) · MicroPort Orthopedics Inc. (15) · Medacta International SA (11) · Biomet Orthopedics, LLC (9) · DePuy Orthopaedics (9) · Smith & Nephew, Inc. (7) · Corin (5)
What is being tested here
Drugs under test in Osteonecrosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest
- Nov 20263D Printing Models in Surgical Planning of Osteotomies in Kienbock´s Disease Stages II-III · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Dec 2026Database Retrieval for the Comprehensive Shoulder · Zimmer Biomet
- Dec 2026Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System · Zimmer Biomet
- Dec 2026The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head · The Cleveland Clinic
- Jan 2027PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty · Zimmer Biomet
- Mar 2027Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty · Medacta International SA
- Apr 2027S-11 SMR TT Hybrid Glenoid and Cementless Finned Short Stem · Limacorporate S.p.a
- Apr 2027Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH · Children's Hospital of Philadelphia
- Apr 2027Bone Quality Evolution in Medication-Related Osteonecrosis of the Jaw Assessed by CBCT (B-ONJ EVOL) · Nantes University Hospital
- Apr 2027The PENTO Protocol in Medication-related Osteonecrosis of the Jaw · University Hospital, Limoges
Who these studies take
Of the 23 Osteonecrosis studies recruiting now, 14 (61%) set no upper age limit and 4 (17%) stop at 75 or younger. 2 (9%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (9%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (4%) | 1 (4%) |
| 18 | 19 (83%) | 19 (83%) |
| 30 | 22 (96%) | 22 (96%) |
| 40 | 22 (96%) | 22 (96%) |
| 50 | 22 (96%) | 22 (96%) |
| 65 | 20 (87%) | 20 (87%) |
| 75 | 20 (87%) | 20 (87%) |
| 85 | 17 (74%) | 17 (74%) |
Across all 286 studies, recruiting or not: 30% stop at 75 or younger and 13% at 65; 16% take children; 1% are for women only and <1% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Osteonecrosis studies take
Of 59 observational studies under Osteonecrosis, half reached primary completion within 141 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 52 mo29–91 · 45 studies | — | — |
| Observational | 141 mo93–184 · 59 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 12, 2026.
Results posted1
- Journey™ UNI Post Market Clinical Follow-UpNov 2, 2026NCT03442231
Studies
Recruiting first, then most recently updated. Showing 50 of 286. Browse all 286 → or search them.
- Leukocyte- and Platelet-Rich Fibrin in the Surgical Treatment of Medication-related Osteonecrosis of the JawNot yet recruitingNCT06419010Not applicable1 country
- E-Type - Early Wear of Polyethylene Liners Used in DMCRecruitingNCT07863557Phase 41 country
- Hydrogel Coating to Reduce Post-surgical Infection After Joint ArthroplastyRecruitingNCT05679232Not applicable1 country
- Daycase Hip and Knee Arthroplasty in Møre and Romsdal TrialNot yet recruitingNCT078340341 country
- Autologous Bone Marrow Aspirate Treatment for Early-Stage OsteonecrosisRecruitingNCT06123481Not applicable1 country
- Exactech Shoulder Post Market Clinical Follow-up StudyRecruitingNCT056037286 countries
- Patient Specific Talus Spacer Post Approval StudyRecruitingNCT053646061 country
- Emerging Indications for Hyperbaric Oxygen TreatmentNot yet recruitingNCT07240649Phase 4
- Bone Marrow Injection in Fracture of Femoral NeckRecruitingNCT07808294Not applicable1 country
- Autologous Platelet Concentrates on the Healing of Extraction SocketsNot yet recruitingNCT07673848Not applicable
- Perform Humeral System StudyRecruitingNCT050675435 countries
- Safety, Tolerability, and Preliminary Efficacy of Intra-Articular Injection of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Non-Traumatic Avascular Necrosis of the Femoral HeadNot yet recruitingNCT07787923Early Phase 1
- Alendronate for Osteonecrosis in Adults With Sickle Cell DiseaseRecruitingNCT06016634Phase 21 country
- Early Warning and Risk Prediction of Medication-Related Osteonecrosis of the JawNot yet recruitingNCT07691892
- Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Shoulder Prosthesis SystemRecruitingNCT076780341 country
- Effect of HBOT on Femoral Head Avascular Necrosis (AVN)Not yet recruitingNCT06931301Not applicable1 country
- The PENTO Protocol in Medication-related Osteonecrosis of the JawRecruitingNCT05795647Phase 21 country
- Bone Quality Evolution in Medication-Related Osteonecrosis of the Jaw Assessed by CBCT (B-ONJ EVOL)Not yet recruitingNCT07588269
- L-PRF in Prevention of ORN and MRONJ Following Tooth Extractions;v3.0Not yet recruitingNCT07585123Not applicable1 country
- 3D Printing Models in Surgical Planning of Osteotomies in Kienbock´s Disease Stages II-IIIRecruitingNCT064609221 country
- Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDHRecruitingNCT03107520Early Phase 11 country
- Marrow Cellution™ vs. Traditional BMA Harvest ProjectRecruitingNCT06388993Not applicable1 country
- Tornier HRS (Humeral Reconstruction System) Study (REVIVE)Enrolling by invitationNCT055000661 country
- Prospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement (PROCLAIM)Enrolling by invitationNCT063113311 country
- Study of the Clinical and Radiographic Results of a Fixed Polyethylene Posteriorly Stabilized Cemented Total Knee Prosthesis With a Minimum Follow-up of 1 Year.RecruitingNCT073134491 country
- G7 Freedom Constrained Vivacit-E LinersEnrolling by invitationNCT05587244Not applicable1 country
- Clinical and Radiological Outcomes of Medacta Shoulder System FRRecruitingNCT059266221 country
- G7 Dual Mobility With Vivacit-E or Longevity PMCFEnrolling by invitationNCT05548972Not applicable4 countries
- MRONJ and Polynucleotides-Hyaluronic Acid Hydrogel (Regenfast®)Not yet recruitingNCT06984107Not applicable
- Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes DiseaseEnrolling by invitationNCT0204071415 countries
- Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis ManagementRecruitingNCT05664815Phase 21 country
- Therapeutic Exposures and Risk Factors in MRONJRecruitingNCT064307621 country
- Immunological Parameters Between MRONJ StagesRecruitingNCT064202841 country
- Local and Systemic Changes in Osteonecrosis of the JawboneEnrolling by invitationNCT053295581 country
- Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral StemEnrolling by invitationNCT041475591 country
- Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCKEnrolling by invitationNCT041454011 country
- Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing InsertEnrolling by invitationNCT048167732 countries
- Medial Wedge Insoles to Improve Gait in Persons After Total Hip ReplacementNot yet recruitingNCT05736016Not applicable
- Post Market Clinical Follow-Up Study Protocol for PROCOTYL® C Acetabular ComponentsEnrolling by invitationNCT035765731 country
- Best Treatment Choice for Osteonecrosis of the JawRecruitingNCT04512638Phase 41 country
- Physica System Total Knee Replacement Registry StudyRecruitingNCT03048201Not applicable1 country
- PROMIS Evaluation StudyRecruitingNCT057346511 country
- S-11 SMR TT Hybrid Glenoid and Cementless Finned Short StemNot yet recruitingNCT05314387
- Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw ReconstructionRecruitingNCT026611391 country
- Validation of the O-bridge Protocol: a Prospective, Multicenter TrialRecruitingNCT040077831 country
- Journey™ UNI Post Market Clinical Follow-UpCompletedNCT034422312 countries
- Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)Active, not recruitingNCT057878211 country
- Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -LaunayActive, not recruitingNCT060126561 country
- Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) StudyCompletedNCT013073841 country
- PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip ArthroplastyActive, not recruitingNCT033722788 countries